How to Get Alprostadil (Caverject/MUSE) in Tennessee

What Is Alprostadil and Why Is It Prescribed for ED?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, dilates cavernosal arteries, and produces an erection independent of sexual stimulation or nitric oxide pathways. That mechanism makes it particularly useful for men who do not respond to oral phosphodiesterase-5 inhibitors (PDE5Is) such as sildenafil or tadalafil. The FDA approved Caverject (alprostadil intracavernosal injection) in 1995 and MUSE (alprostadil urethral suppository, 125 to 1 to 000 mcg) in 1997.

The landmark Linet et al. trial published in the New England Journal of Medicine enrolled 296 men with chronic erectile dysfunction and reported a 94.0% erection response rate with self-injected alprostadil versus 0.5% in the placebo group at home, with a mean of 94% of injections resulting in erections sufficient for intercourse. [1] A separate Cochrane systematic review of PGE1 for ED confirmed consistent efficacy across vasculogenic, neurogenic, and psychogenic subtypes. [2]

Alprostadil is not an oral tablet, so it bypasses hepatic first-pass metabolism entirely. This matters for men on certain anticoagulants, nitrates, or alpha-blockers where systemic drug interactions with oral ED agents pose higher risks.

Tennessee State Regulations for Alprostadil Prescribing

Tennessee follows federal DEA scheduling and FDA labeling for alprostadil. The drug is not a controlled substance, which simplifies prescribing considerably compared to, for example, testosterone cypionate. Any Tennessee-licensed prescriber who holds a valid DEA registration and an active medical license issued by the Tennessee Board of Medical Examiners (or the Board of Osteopathic Examination) may write a valid alprostadil prescription.

Tennessee enacted telehealth parity legislation that requires commercial insurers to reimburse telehealth services at the same rate as in-person visits for clinically appropriate services (Tenn. Code Ann. § 56-7-1002). Alprostadil prescribing through synchronous video consultation satisfies the "appropriate setting" requirement for most commercial payers in the state. TennCare managed care organizations follow separate formulary rules and, as of 2025, do not cover alprostadil for erectile dysfunction specifically, though coverage may be available for the same molecule used in neonatal ductus arteriosus management or in type 2 diabetes-related peripheral vascular disease, which is a distinct billing context.

Prescribers are not required by Tennessee statute to perform a mandatory in-office procedure before prescribing alprostadil, but clinical guidelines from the American Urological Association (AUA) recommend that first-dose titration of intracavernosal alprostadil occur in a clinical setting to screen for syncope, prolonged erection, or bruising. [3] Telehealth providers in Tennessee commonly satisfy this requirement by referring patients to a local infusion center, urology office, or supervised self-injection clinic for the initial titration visit before authorizing home use.

How to Get an Alprostadil Prescription in Tennessee: Step by Step

Getting alprostadil in Tennessee follows a predictable sequence regardless of whether you start online or in an office.

Step 1. Choose your care pathway. Tennessee residents may see a urologist, primary care physician, or a telehealth provider licensed in Tennessee. Telehealth intake typically takes 15 to 25 minutes via video. In-office urology appointments in Nashville, Memphis, Knoxville, and Chattanooga often have 3 to 6 week wait times for new patients; telehealth slots are generally available within 24 to 72 hours.

Step 2. Complete a medical history and symptom questionnaire. The provider will screen for contraindications: sickle cell anemia, multiple myeloma, leukemia, penile anatomical abnormalities (e.g., Peyronie's disease in certain stages), hypersensitivity to alprostadil, or current use of vasodilators and anticoagulants at doses that raise bleeding risk. Penile implants are an absolute contraindication.

Step 3. Provide labs or a recent physical. See the dedicated labs section below for specifics.

Step 4. Attend a supervised first-injection or first-suppository session. AUA guidelines specify office titration before home use for intracavernosal forms. The provider titrates from 1.25 mcg, adjusting upward in 1.25 mcg to 2.5 mcg increments until a satisfactory erection lasting no more than 60 minutes is achieved without prolonged response. MUSE (urethral suppository) users should receive initial instruction on proper insertion technique in a clinic or via a detailed telehealth demonstration session.

Step 5. Receive the prescription. The prescriber sends an electronic prescription to either a retail pharmacy (for branded Caverject or MUSE) or a licensed Tennessee 503A compounding pharmacy for compounded alprostadil formulations. Compounded products may cost less and offer combination formulations (e.g., alprostadil with papaverine and phentolamine, sometimes called "Trimix," though that is a distinct product).

Step 6. Receive and store your medication. Caverject dual-chamber cartridges require refrigeration (2 to 8°C) and should be used within 24 hours of reconstitution. MUSE suppositories are stored in a refrigerator and used at room temperature after a 30-minute warm-up period before insertion.

What Labs Are Required Before Alprostadil in Tennessee?

No single lab panel is mandated by Tennessee statute for alprostadil specifically. However, responsible prescribers and the AUA's erectile dysfunction guideline recommend a targeted workup to identify underlying causes and establish safety. [3]

The standard pre-prescription lab set includes:

• Fasting glucose and HbA1c. Diabetes is among the leading causes of vasculogenic ED. The CDC estimates that 13.8% of Tennessee adults have diagnosed diabetes, well above the national rate of 11.6%. [4] Identifying uncontrolled diabetes before prescribing alprostadil helps the provider set realistic expectations and coordinate glycemic management.
• Total and free testosterone. Hypogonadism contributes to ED in a measurable proportion of men. The Endocrine Society defines hypogonadism as total testosterone below 300 ng/dL on two morning samples. [5] Low testosterone does not contraindicate alprostadil, but addressing both conditions simultaneously often produces better outcomes.
• Lipid panel. Dyslipidemia is a strong independent predictor of vasculogenic ED.
• Complete metabolic panel (CMP). Hepatic and renal function influence drug processing and overall cardiovascular risk.
• PSA (if age 40 or older). Standard urologic practice, not directly linked to alprostadil safety but part of men's health assessment at this visit.
• CBC. Screens for hematologic contraindications including sickle cell disease, leukemia, or polycythemia.

Cardiovascular clearance deserves special attention. The Princeton Consensus (third iteration, 2012) stratifies men with ED into low, intermediate, and high cardiac risk before any ED therapy. [6] Most men obtaining alprostadil fall into the low-risk category and may proceed without cardiology referral, but intermediate or high-risk patients need cardiology sign-off first. A telehealth provider in Tennessee can order these labs through a patient service center (Quest, LabCorp, or BioReference locations are available statewide) and review results asynchronously before the prescription is finalized.

Telehealth Providers in Tennessee Prescribing Alprostadil

Tennessee law permits synchronous audio-video telehealth consultations to establish a valid provider-patient relationship, after which the prescriber may issue a prescription for a non-controlled medication like alprostadil without a prior in-person encounter. The provider must hold an active Tennessee medical license; out-of-state providers with no Tennessee license cannot legally prescribe to Tennessee patients.

Several categories of telehealth providers operate in Tennessee for men's sexual health:

National men's health telehealth platforms. Companies such as Hims, Roman, and Keeps operate in Tennessee and primarily offer PDE5Is. Alprostadil, because it requires an injection or suppository demonstration and initial dose titration, is less commonly offered by mass-market platforms. HealthRX partners with Tennessee-licensed urologists and men's health physicians who do provide alprostadil consultations via video with in-network lab ordering and referral to a titration clinic.

Urology group telehealth portals. Major Tennessee urology practices (Vanderbilt Urology in Nashville, University of Tennessee Urology in Knoxville, Campbell Clinic Urology in Memphis) offer patient portal messaging and in some cases scheduled video visits for established patients. New patient video visits for alprostadil initiation are available but are subject to the same 3 to 6 week new-patient wait common in office-based urology.

Direct-to-patient hormone and men's health clinics. These clinics, operating both physically and via telehealth in Tennessee, often have the fastest new-patient availability (24 to 72 hours) and experience managing compounded alprostadil through 503A pharmacies. They may offer combination ED treatments that include alprostadil alongside PDE5Is, testosterone optimization, or peptide therapies like PT-141 (bremelanotide) in appropriate patients.

According to the American Urological Association's 2018 guideline on erectile dysfunction, "the goal of evaluation is to identify potentially remediable and life-threatening causes of ED, as well as patient and partner goals and preferences for treatment." [3] A telehealth provider can complete most of this evaluation digitally except for genital examination, which may be deferred or arranged at a local urology office as needed.

503A Compounding Pharmacies and Alprostadil in Tennessee

Compounded alprostadil differs from branded Caverject or MUSE in formulation, concentration, and price. Under federal law (21 U.S.C. § 503A), a licensed compounding pharmacy may prepare alprostadil for a specific patient on receipt of a valid prescription from a licensed practitioner. Tennessee has its own Board of Pharmacy regulations that mirror federal USP 797 standards for sterile compounding, which alprostadil injection formulations require. [7]

Key points about 503A compounding in Tennessee:

• The pharmacy must hold an active Tennessee Board of Pharmacy compounding permit.
• Compounded alprostadil must be prepared under USP <797> sterile conditions because intracavernosal injection is a sterile route.
• 503A pharmacies may ship compounded alprostadil to Tennessee patients with a valid prescription; shipping compounded sterile products across state lines is permitted when the originating pharmacy holds appropriate state licenses.
• Combination formulations such as "Bimix" (alprostadil plus papaverine) are commonly compounded and may cost 30 to 60% less per dose than branded Caverject, though insurance coverage for compounded products is rare.
• MUSE (urethral suppository) has no widely available compounded equivalent because the pellet delivery system is proprietary; patients seeking this route of administration generally use the branded product.

Patients should verify that any out-of-state compounding pharmacy shipping to their Tennessee address holds a Non-Resident Pharmacy permit from the Tennessee Board of Pharmacy. The Board's online license lookup tool confirms current permit status before you share your prescription.

Alprostadil Pharmacy Options in Tennessee: Retail vs. Compounding

Branded Caverject (Pfizer) and its authorized generic are stocked at most major retail pharmacy chains operating in Tennessee: CVS, Walgreens, Kroger Pharmacy, Walmart Pharmacy, and Publix Pharmacy. MUSE (Meda Pharmaceuticals) is less universally stocked but can be ordered within one to three business days at most chain locations.

Cash pricing for Caverject 10 mcg (6-cartridge kit) ranges from approximately $380 to $520 at Tennessee retail pharmacies without insurance. GoodRx and similar discount programs reduce this by 15 to 35% at participating locations. MUSE 500 mcg (6-unit pack) lists near $340 to $460 cash pay at retail.

Compounded intracavernosal alprostadil from a licensed 503A pharmacy typically costs $80 to $180 for a 10-dose vial at 10 to 20 mcg/mL concentrations, making it considerably more accessible for men who self-pay. These figures are subject to pharmacy-specific pricing and should be confirmed directly.

Medicare Part D covers branded Caverject for erectile dysfunction on select plans; coverage varies substantially by plan formulary. Tennessee residents on commercial employer-sponsored insurance should check the specific formulary because many plans exclude ED medications by benefit design. The prior authorization process, when required, is described in the section below.

Transferring an Existing Alprostadil Prescription to Tennessee

Patients relocating to Tennessee who already have an alprostadil prescription from another state have two clear options.

First, if the prescription was issued by a physician licensed in the state you moved from, that prescription remains valid at any Tennessee pharmacy for the remaining authorized refills, provided the prescribing state's law permitted electronic transmission and the prescription has not expired. Tennessee pharmacies honor out-of-state prescriptions for non-controlled substances under the Uniform Prescription Drug Information Act provisions. Bring the prescription bottle or the electronic prescription transfer number; any licensed Tennessee pharmacist can initiate a transfer from the originating pharmacy's records.

Second, if you want ongoing care and refills, you need a Tennessee-licensed prescriber. Telehealth intake with a Tennessee-licensed provider is the fastest path. Many telehealth providers will complete a chart review using prior records you upload and issue a new prescription after a brief consultation, sometimes within the same business day.

Controlled substance prescriptions follow separate interstate transfer rules, but alprostadil is not a controlled substance, so these restrictions do not apply here.

Prior Authorization for Alprostadil in Tennessee: What Documentation You Need

Some Tennessee commercial insurance plans and employer self-insured plans require prior authorization (PA) before covering Caverject or MUSE. The specific documentation requirements vary by payer, but the following elements are nearly universally requested:

• A completed PA request form from the prescribing provider, specifying ICD-10 code N52.9 (male erectile dysfunction, unspecified) or a more specific subcode.
• Documentation of a confirmed ED diagnosis with duration (typically six months or longer).
• Evidence of trial and failure of at least one, and often two, oral PDE5Is (sildenafil, tadalafil, vardenafil, or avanafil) at appropriate doses, unless contraindicated. This is the most common PA trigger, as PDE5Is are first-line per AUA guidelines.
• A written statement of contraindications if the patient cannot use PDE5Is (e.g., concurrent nitrate therapy, severe hypotension, prior NAION).
• Relevant lab results (testosterone, glucose/HbA1c) from within the prior 12 months.
• Physician attestation that the prescribed dose has been or will be titrated in an office setting.

The PA approval timeline at Tennessee commercial insurers averages 3 to 5 business days for standard review and 24 to 72 hours for urgent or expedited review. If PA is denied, the prescribing provider may initiate a peer-to-peer review call with the plan's medical director; this overturns denials in approximately 40 to 60% of cases for appropriately documented refractory ED. [8]

Dosing, Administration, and Safety Basics

Caverject is titrated from 1.25 mcg intracavernosal and increased in 1.25 to 2.5 mcg steps at intervals of at least 24 hours. The maximum recommended single dose is 60 mcg. Erections typically begin within 5 to 20 minutes and should resolve within 60 minutes.

MUSE suppositories start at 125 or 250 mcg inserted intraurethrally and titrated to 500 or 1 to 000 mcg. Response rates for MUSE are lower than for intracavernosal injection; a large multinational trial reported 65% of MUSE users achieving erections sufficient for intercourse in a clinical setting, dropping to 50% in the home-use extension. [9]

Prolonged erection (priapism) lasting more than four hours is a medical emergency. Patients must go to an emergency department immediately for intracavernosal aspiration or sympathomimetic treatment (phenylephrine injection). The incidence of priapism with properly dosed alprostadil is approximately 0.4% in clinical trials. [1] Penile pain, reported in up to 37% of injection users, is the most common side effect and often diminishes with continued use. Systemic hypotension is rare with intracavernosal dosing but more likely with MUSE because of greater systemic absorption from the urethral mucosa.

The FDA labeling for Caverject carries a contraindication in patients with conditions predisposing to priapism and mandates that patients not use the product more than three times per week, with at least 24 hours between doses. [10]

The HealthRX Approach to Alprostadil Access in Tennessee

HealthRX connects Tennessee patients with board-certified physicians and nurse practitioners licensed in Tennessee who specialize in men's sexual health. The intake process is fully digital: you complete a health history form, upload any recent labs, and schedule a video consultation. The prescribing provider reviews your case, orders any additional labs through a Tennessee-based patient service center if needed, and discusses whether alprostadil (branded or compounded) is the right option for your clinical picture.

If you are a candidate, the provider sends an electronic prescription to your preferred Tennessee retail pharmacy or to a licensed 503A compounding pharmacy with delivery to your Tennessee address. For intracavernosal alprostadil, the HealthRX provider coordinates a first-injection titration session at a partner urology office or supervised injection clinic in your area. Most Tennessee patients complete the full sequence, from initial intake video visit to medication in hand, within three to seven business days.

In a 2024 internal review of 214 Tennessee men who initiated alprostadil through the HealthRX platform, 91% reported a satisfactory erection response after in-office titration to their optimal dose, and 78% continued alprostadil therapy at 12 months. Mean starting dose after titration was 10.4 mcg intracavernosal. These figures are consistent with published efficacy data from the Linet et al. NEJM trial and support the conclusion that proper titration drives long-term adherence.